NIPH Clinical Trials Search

Evaluation of Hepatic and Renal Function Algorithms for Fosravuconazole

Basic Information

Recruitment status	Not Recruiting
Health condition(s) or Problem(s) studied	Onychomycosis
Date of first enrollment	01/11/2025
Target sample size	130
Countries of recruitment
Study type	Observational
Intervention(s)

Outcome(s)

Primary Outcome	AST, ALT,GGT, SCr, and eGFR
Secondary Outcome	Fold-change values of AST, ALT, GGt, SCr, and eGFR

Key inclusion & exclusion criteria

Age minimum	Not applicable
Age maximum	Not applicable
Gender
Include criteria	patients diagnosed with onychomycosis by direct microscopy, treated with fosravuconazole between 20 March 2023 and 31 July 2025, and who underwent two laboratory tests: baseline and follow-up, during treatment.
Exclude criteria	none